Table 2.
BNT162b Recipients | mRNA-1273 Recipients | |||
---|---|---|---|---|
Demographic Category | Total | Cases | Total | Cases |
Female, age in years | 2350 | 0 | 1275 | 14 |
18–30 | 298 | 0 | 213 | 1 |
31–45 | 1081 | 0 | 557 | 11 |
46–65 | 914 | 0 | 480 | 2 |
>65 | 56 | 0 | 25 | 0 |
Male, age in years | 1249 | 0 | 675 | 0 |
18–30 | 132 | 0 | 71 | 0 |
31–45 | 504 | 0 | 281 | 0 |
46–65 | 535 | 0 | 286 | 0 |
>65 | 76 | 0 | 36 | 0 |
Nonbinary, age in years | 13 | 0 | 5 | 0 |
18–30 | 1 | 0 | 1 | 0 |
31–45 | 8 | 0 | 2 | 0 |
46–65 | 3 | 0 | 2 | 0 |
>65 | 1 | 0 | 0 | 0 |
Age data were missing for 1 female recipient and 2 male recipients of the BNT162b vaccine and for 1 male recipient of the mRNA-1273 vaccine.